Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting (Transcript)
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting (Transcript)
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
TRACON Pharmaceuticals announces orphan drug designation for envafolimab in soft tissue sarcoma
Proactive Investors
TRACON Pharmaceuticals Inc (NASDAQ:TCON) has announced that the US Food and Drug Administration (FDA) has granted orphan drug..
-
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)
SeekingAlpha
-
Merck & Co., Inc. (MRK) Management Presents at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Conference (Transcript)
SeekingAlpha
-
Amgen Inc.'s (AMGN) Management Presents at American Society of Clinical Oncology Annual Meeting Conference (Transcript)
SeekingAlpha
-
Wall Street ends solidly in the green despite jobs data miss
Proactive Investors
Advertisement
More coverage
NA Proactive news snapshot: PlantX Life, Predictiv AI, CleanSpark, GreenBank Capital UPDATE ...
Proactive Investors
Universal Ibogaine Inc (UI) and capital pool company P Squared Renewables Inc (PSQ) announced that they had brought on board US..
-
Wall Street solidly in the green despite jobs data miss
Proactive Investors
-
NA Proactive news snapshot: Predictiv AI, TRACON Pharmaceuticals, GGX Gold, Alpine 4 Holdings, GreenBank Capital UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: TRACON Pharmaceuticals, GGX Gold, Alpine 4 Holdings, GreenBank Capital UPDATE ...
Proactive Investors
-
TRACON Pharmaceuticals presents Phase 1 study data of uliledlimab and atezolizumab at American Society of Clinical Oncology meeting
Proactive Investors